Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of 10.56% is 13198% above its 5-year average of 0.08%, near the high end of its 5-year range (-106.98%–26.98%).
1.34% above its 12-month average of 10.42%.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-07-04): 6.01%.
NET PROFIT MARGIN
10.56%
NET PROFIT MARGIN AVG TTM
10.42%
NET PROFIT MARGIN AVG 3Y
1.25%
NET PROFIT MARGIN AVG 5Y
0.08%
NET PROFIT MARGIN AVG 10Y
N/A
NET PROFIT MARGIN AVG 15Y
N/A
NET PROFIT MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+1.34%
CURRENT VS 3Y AVG
+744.08%
CURRENT VS 5Y AVG
+13197.52%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 504 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Aveanna Healthcare Holdings Inc.
Market Cap
$2.68B
Net Profit Margin
10.56%
TTM Avg
10.42%
3Y Avg
1.25%
5Y Avg
0.08%
Market Cap
$2.68B
Net Profit Margin
-33.44%
TTM Avg
-12.59%
3Y Avg
-3.87%
5Y Avg
-6.56%
Market Cap
$2.69B
Net Profit Margin
-40.18%
TTM Avg
-20.09%
3Y Avg
-20.09%
5Y Avg
-20.09%
Market Cap
$2.76B
Net Profit Margin
-54.75%
TTM Avg
-325.19%
3Y Avg
-290.00%
5Y Avg
-135445.82%
Market Cap
$2.85B
Net Profit Margin
1.85%
TTM Avg
-5.88%
3Y Avg
-8.36%
5Y Avg
-6.41%
Market Cap
$2.90B
Net Profit Margin
22.69%
TTM Avg
19.73%
3Y Avg
-2.42%
5Y Avg
-44.65%
Market Cap
$2.53B
Net Profit Margin
-945.92%
TTM Avg
-825.68%
3Y Avg
-750.64%
5Y Avg
-1236.10%
Market Cap
$2.89B
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$2.45B
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Aveanna Healthcare Holdings Inc. (AVAH) | $2.68B | 10.56% | 10.42% | 1.25% | 0.08% |
| Acadia Healthcare Company, Inc. (ACHC)vs › | $2.68B | -33.44% | -12.59% | -3.87% | -6.56% |
| Alamar Biosciences, Inc. (ALMR)vs › | $2.69B | -40.18% | -20.09% | -20.09% | -20.09% |
| Beam Therapeutics Inc. (BEAM)vs › | $2.76B | -54.75% | -325.19% | -290.00% | -135445.82% |
| AtriCure, Inc. (ATRC)vs › | $2.85B | 1.85% | -5.88% | -8.36% | -6.41% |
| TransMedics Group, Inc. (TMDX)vs › | $2.90B | 22.69% | 19.73% | -2.42% | -44.65% |
| Recursion Pharmaceuticals, Inc. (RXRX)vs › | $2.53B | -945.92% | -825.68% | -750.64% | -1236.10% |
| Dyne Therapeutics, Inc. (DYN)vs › | $2.89B | 0.00% | 0.00% | 0.00% | 0.00% |
| Disc Medicine, Inc. (IRON)vs › | $2.45B | 0.00% | 0.00% | 0.00% | 0.00% |
| Clover Health Investments, Corp. (CLOV)vs › | $2.43B | -0.74% | -3.79% | -13.87% | -19.28% |
Operating Margin
11.1%
Net Profit Margin
10.6%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-07-04 | 6.01% |
| 2026-04-04 | 6.43% |
| 2026-01-03 | 26.98% |
| 2025-09-27 | 2.26% |
| 2025-06-28 | 4.58% |
| 2025-03-29 | 0.93% |
| 2024-12-28 | 5.61% |
| 2024-09-28 | -8.42% |
| 2024-06-29 | 2.75% |
| 2024-03-30 | -2.28% |
| 2023-12-30 | -5.37% |
| 2023-09-30 | -21.42% |
| 2023-07-01 | 5.42% |
| 2023-04-01 | -6.86% |
| 2022-12-31 | -52.71% |
| 2022-10-01 | 5.48% |
| 2022-07-02 | -106.98% |
| 2022-04-02 | 5.62% |
| 2022-01-01 | -30.48% |
| 2021-10-02 | 0.51% |
| 2021-07-03 | 0.29% |
| 2021-04-03 | 1.39% |
| 2020-12-31 | -2.30% |
| 2020-09-30 | -2.02% |
| 2020-06-30 | -22.06% |
| 2020-03-31 | 10.60% |
